Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1971-65-9

1971-65-9

Post Buying Request

1971-65-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1971-65-9 Usage

Uses

Δ6,7-Estradiol 3,17-Diacetate is an intermediate in synthesizing 17β-Dihydro Equilenin (D448960), a 17β-metabolite of Equilin (E592800).

Check Digit Verification of cas no

The CAS Registry Mumber 1971-65-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,9,7 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1971-65:
(6*1)+(5*9)+(4*7)+(3*1)+(2*6)+(1*5)=99
99 % 10 = 9
So 1971-65-9 is a valid CAS Registry Number.

1971-65-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name Estra-1,3,5(10),6-tetraene-3,17β-diol Diacetate

1.2 Other means of identification

Product number -
Other names 3,17β-Diacetoxy-oestra-1,3,5(10),6-tetraen

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1971-65-9 SDS

1971-65-9Relevant articles and documents

Cytoprotective steroids (II)

-

, (2008/06/13)

A method is provided for treating a patient in need of therapy for acute neuronal degeneration due to metabolic compromise of central or peripheral nervous system cells comprising administering to that patient a therapeutically effective amount of a 7α-hydroxy substituted steroid selected from 7α-hydroxy-derivatives of estradiols, dehydroepiandrosterones and pregnenolones, and metabolic precursors thereof. Use of such compounds for manufacture of medicaments and neuroprotective compositions are also provided.

Iodoestrogens, syntheses, and interaction with uterine receptors.

Arunachalam et al.

, p. 5900,5904 (2007/10/12)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1971-65-9